BioLife Solutions Inc., a supplier of bioproduction tools and services, announced that all of its SciSafe-branded biostorage facilities in the USA have been accredited by the College of American Pathologists (CAP).

The CAP Laboratory Accreditation is awarded to laboratories that meet very stringent requirements and maintain the highest standard of quality, accuracy, and consistency, considered equal to or more rigorous than the U.S. federal government’s inspection program.

Related: BioLife Launches Phase Change Material Accessory for Biologic Material Storage

“All SciSafe facilities in the U.S. have earned the prestigious CAP-BAP accreditation, demonstrating our continual commitment to our mission of providing superior quality biostorage services,” says Karen Foster, global chief quality officer at BioLife Solutions.

SciSafe Biostorage Centers of Excellence are now compliant to the following standards:

  • ISO 9001
  • ISO 20387
  • cGMP FDA compliant
  • FDA registered and inspected since 2011 (CDER and CBER)
  • GDP (Good Distribution Practice)
  • CAP-BAP accredited in US facilities as of 2023

Adds Garrie Richardson, SciSafe general manager, “We are proud to receive what is recognized as the highest quality standard to build upon our already impressive list of certifications – offering our clients the best level of protection for their precious biological material.”

About CAP Accreditation

Pioneered in 2012, the CAP Biorepository Accreditation Program was the first accreditation program designed to improve the quality and consistency of biorepositories. Drawing on best practices from ISBER, NCI, OECD, CMS and the Laboratory Accreditation Program, the goal of the program is to provide requirements for standardization of processes that will result in high-quality human specimens and genetic materials that can be used to support research. Recently, CAP physician members contributed to the ISO technical committee that developed the ISO 20387 standard for biobanking.